Cargando…
Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
Alzheimer’s disease (AD), once considered a rare disease, is now the most common form of dementia in the elderly population. Current drugs (cholinesterase inhibitors and glutamate antagonists) are safe but of limited benefit to most patients, offering symptomatic relief without successful cure of th...
Autores principales: | Miculas, Denisa Claudia, Negru, Paul Andrei, Bungau, Simona Gabriela, Behl, Tapan, Hassan, Syed Shams ul, Tit, Delia Mirela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818415/ https://www.ncbi.nlm.nih.gov/pubmed/36611925 http://dx.doi.org/10.3390/cells12010131 |
Ejemplares similares
-
Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses
por: Negru, Paul Andrei, et al.
Publicado: (2022) -
Characterization of the Toxicological Impact of Heavy Metals on Human Health in Conjunction with Modern Analytical Methods
por: Filipoiu, Dana Claudia, et al.
Publicado: (2022) -
Exploring New Therapeutic Avenues for Ophthalmic Disorders: Glaucoma-Related Molecular Docking Evaluation and Bibliometric Analysis for Improved Management of Ocular Diseases
por: Bodea, Flaviu, et al.
Publicado: (2023) -
Highlighting the Benefits of Rehabilitation Treatments in Hip Osteoarthritis
por: Radu, Andrei-Flavius, et al.
Publicado: (2022) -
Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
por: Negru, Paul Andrei, et al.
Publicado: (2022)